When Hydrolysis Stops Being the Bottleneck: Redefining AD Performance at Plant Scale
Company: Clinty Bio in partnership with ALPS Ecoscience
Country: UK
A biology-led transformation of anaerobic digestion that unlocks substantial unused capacity in existing plants. By combining advanced feedstock characterisation, biological interpretation, laboratory testing, pilot-scale validation, and retrofit-friendly process optimisation, Clinty Bio enables plants to overcome the biological constraints that limit performance. This includes the commissioning of dedicated hydrolysis capacity seeded with Clinty Bio’s own inoculum, allowing complex organic material to be biologically conditioned before downstream methane production. The approach supports stable operation at higher organic loading rates while improving gas quality, reducing feedstock demand, lowering failure risk, and increasing resilience to challenging feedstocks. Proven at both pilot and full scale, Clinty Bio has delivered increased methane output per unit volume, rapid recovery of failed plants, and sustained long-term stability. Collectively, this demonstrates a low-CAPEX, scalable pathway to improve the efficiency, resilience, and sustainability of the anaerobic digestion sector.
